Literature DB >> 29706316

Mutations inside rifampicin-resistance determining region of rpoB gene associated with rifampicin-resistance in Mycobacterium tuberculosis.

Myo T Zaw1, Nor A Emran1, Zaw Lin2.   

Abstract

BACKGROUND: Rifampicin (RIF) plays a pivotal role in the treatment of tuberculosis due to its bactericidal effects. Because the action of RIF is on rpoB gene encoding RNA polymerase β subunit, 95% of RIF resistant mutations are present in rpoB gene. The majority of the mutations in rpoB gene are found within an 81bp RIF-resistance determining region (RRDR).
METHODOLOGY: Literatures on RIF resistant mutations published between 2010 and 2016 were thoroughly reviewed.
RESULTS: The most commonly mutated codons in RRDR of rpoB gene are 531, 526 and 516. The possibilities of absence of mutation in RRDR of rpoB gene in MDR-TB isolates in few studies was due to existence of other rare rpoB mutations outside RRDR or different mechanism of rifampicin resistance.
CONCLUSION: Molecular methods which can identify extensive mutations associated with multiple anti-tuberculous drugs are in urgent need so that the research on drug resistant mutations should be extended.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Mutations; Mycobacterium tuberculosis; Rifampicin resistance; Rifampicin-resistance determining region; rpoB gene

Mesh:

Substances:

Year:  2018        PMID: 29706316     DOI: 10.1016/j.jiph.2018.04.005

Source DB:  PubMed          Journal:  J Infect Public Health        ISSN: 1876-0341            Impact factor:   3.718


  36 in total

1.  Occult drug resistance in tuberculosis: Emerging issues, upcoming challenges & possible solutions.

Authors:  Baijayantimala Mishra; Prasanta Raghab Mohapatra
Journal:  Indian J Med Res       Date:  2020-06       Impact factor: 2.375

2.  Epidemiology of molecular probes in Xpert MTB/RIF assay in Khyber Pakhtunkhwa, Pakistan.

Authors:  Anwar Sheed Khan; Muhammad Tahir Khan; Sajid Ali; Taj Ali Khan; Muhammad Qasim; Arif Malik; Sajid Ali; Wasim Sajjad; Qurrat Ul Ain; Muhammad Irfan
Journal:  Arch Microbiol       Date:  2021-02-27       Impact factor: 2.552

3.  Risk Factors Associated with Antibiotic Treatment Failure of Buruli Ulcer.

Authors:  Daniel P O'Brien; N Deborah Friedman; Aaron Walton; Andrew Hughes; Eugene Athan
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

4.  Rifampicin-Mediated Metabolic Changes in Mycobacterium tuberculosis.

Authors:  Soujanya D Yelamanchi; Archita Mishra; Santosh Kumar Behra; Gayathree Karthikkeyan; Thottethodi Subrahmanya Keshava Prasad; Avadhesha Surolia
Journal:  Metabolites       Date:  2022-05-29

5.  Elevated Levels of Three Reactive Oxygen Species and Fe(II) in the Antibiotic-Surviving Population of Mycobacteria Facilitate De Novo Emergence of Genetic Resisters to Antibiotics.

Authors:  Avraneel Paul; Rashmi Ravindran Nair; Kishor Jakkala; Atul Pradhan; Parthasarathi Ajitkumar
Journal:  Antimicrob Agents Chemother       Date:  2022-04-18       Impact factor: 5.938

Review 6.  Mechanisms of Drug-Induced Tolerance in Mycobacterium tuberculosis.

Authors:  Sander N Goossens; Samantha L Sampson; Annelies Van Rie
Journal:  Clin Microbiol Rev       Date:  2020-10-14       Impact factor: 26.132

7.  Probing the Molecular Mechanism of Rifampin Resistance Caused by the Point Mutations S456L and D441V on Mycobacterium tuberculosis RNA Polymerase through Gaussian Accelerated Molecular Dynamics Simulation.

Authors:  Qianqian Zhang; Shuoyan Tan; Tong Xiao; Hongli Liu; Syed Jawad Ali Shah; Huanxiang Liu
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

8.  Characterization of Fluoroquinolone-Resistant and Multidrug-Resistant Mycobacterium tuberculosis Isolates Using Whole-Genome Sequencing in Tianjin, China.

Authors:  Zhirui Wang; Rui Sun; Cheng Mu; Chunhua Wang; Hui Zhao; Lina Jiang; Hanfang Ju; Wenxi Dai; Fan Zhang
Journal:  Infect Drug Resist       Date:  2022-04-13       Impact factor: 4.177

9.  Mutational Frequencies in Mycobacterial rpoB gene using GeneXpert/MTB Rif Assay in Rifampicin Resistant patients at a tertiary care setting in Urban Sindh, Pakistan: Analysis from a Five-Year Period.

Authors:  Muhammad Alamgir; Mehwish Sajjad; Mirza Saifullah Baig; Muhammad Yahya Noori
Journal:  Pak J Med Sci       Date:  2021 Jul-Aug       Impact factor: 1.088

10.  Generation of Tetracycline and Rifamycin Resistant Chlamydia Suis Recombinants.

Authors:  Hanna Marti; Sankhya Bommana; Timothy D Read; Theresa Pesch; Barbara Prähauser; Deborah Dean; Nicole Borel
Journal:  Front Microbiol       Date:  2021-06-30       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.